DJ AstraZeneca PLC ADR Falls Wednesday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
The AstraZeneca PLC ADR $(AZN)$ sank 0.09% to $76.97 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.40% to 16,742.39 and the Dow Jones Industrial Average rising 0.88% to 39,908.00.
This was the ADR's second consecutive day of losses.
AstraZeneca PLC ADR closed $0.97 short of its 52-week high ($77.94), which the company achieved on May 10th.
The ADR underperformed when compared to some of its competitors Wednesday, as Eli Lilly & Co. $(LLY)$ rose 3.19% to $787.02, Biogen Inc. $(BIIB)$ rose 3.72% to $235.32, and Johnson & Johnson $(JNJ)$ rose 0.85% to $152.67.
Trading volume (3.9 M) remained 1.7 million below its 50-day average volume of 5.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 15, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 15, 2024 17:26 ET (21:26 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments